In lung carcinoma, a machine learning model could associate MYL6 expression with an “alive without cancer” group, and in a neuroblastoma patient cohort, a higher intratumoral expression of MYL6 promised a better outcome [30,31]. Here, MYL6 is linked to lung carcinoma.